首页> 外国专利> Methods for the diagnosis and Treatment of patients with critical illness, and the use of Endothelin and Endothelin agonists with vasoconstrictor activity in the preparation of drugs for the treatment of patients with critical illness

Methods for the diagnosis and Treatment of patients with critical illness, and the use of Endothelin and Endothelin agonists with vasoconstrictor activity in the preparation of drugs for the treatment of patients with critical illness

机译:诊断和治疗重症患者的方法,以及具有血管收缩活性的内皮素和内皮素激动剂在制备用于治疗重症患者的药物中的用途

摘要

The ratio of the concentrations of immunoreactivity (proadm) / (proendotelina midregional pro end) in body Fluids of patients with critical illness are used for diagnosis, Monitoring and prognosis of the course, including the assessment of the risk of mortality, ENFE Rmedades severe life-threatening.In addition, Treatment of patients with critical illness with high levels of inmunorreactividades pro ADM but insufficient levels of pro - end with a drug that comprises by Endothelin vasoconstriction or their precursors and / or adrenomedullin Endothelin agonists or antagonists.
机译:危重病患者体液中免疫反应性浓度(proadm)//(中间区域proendotelina浓度)的比率用于诊断,监测和预后病程,包括评估死亡风险,ENFE Rmedades严重此外,用内皮素血管收缩素或其前体和/或肾上腺髓质素内皮素激动剂或拮抗剂所含药物治疗高危ADM病原反应的严重疾病患者,但前药水平不足。

著录项

  • 公开/公告号AR051870A1

    专利类型

  • 公开/公告日2007-02-14

    原文格式PDF

  • 申请/专利权人 B.R.A.H.M.S. AKTIENGESELLSCHAFT;

    申请/专利号AR2005P105538

  • 发明设计人

    申请日2005-12-26

  • 分类号G01N33/68;A61K38/22;A61P9/12;G01N33/48;G01N33/543;G01N33/74;G06F17/60;G06F19/00;G06F159/00;

  • 国家 AR

  • 入库时间 2022-08-21 20:59:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号